APA (7th ed.) Citation

WJ, S., LC, M., NB, M., D, P., B, B., S, L., . . . S, G. (2021). PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis. Gastroenterology, 161(6), 1853. https://doi.org/10.1053/j.gastro.2021.08.045

Chicago Style (17th ed.) Citation

WJ, Sandborn, et al. "PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis." Gastroenterology 161, no. 6 (2021): 1853. https://doi.org/10.1053/j.gastro.2021.08.045.

MLA (9th ed.) Citation

WJ, Sandborn, et al. "PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis." Gastroenterology, vol. 161, no. 6, 2021, p. 1853, https://doi.org/10.1053/j.gastro.2021.08.045.